Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Ustekinumab

First report of malignant melanoma: case report

    • 19 Accesses

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      Ehmann LM, Tillack-Schreiber C, Brand S, Wollenberg A.Malignant melanoma during ustekinumab therapy of Crohn's disease. Inflammatory Bowel Diseases 18: E199-E200, No. 1, Jan 2012. Available from: URL: http://dx.doi.org/10.1002/ibd.21877 - Germany

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Ustekinumab. React. Wkly. 1389, 41 (2012). https://doi.org/10.2165/00128415-201213890-00152

    Download citation

    Keywords

    • Public Health
    • Malignant Melanoma
    • Patient Outcome
    • Congenital Anomaly
    • Infliximab